4-氟-2-甲基苯胺 、 氰乙酸乙酯 以
ethyl acetate n-hexane 为溶剂,
反应 4.0h,
以to give the title compound (4.0 g, 67%) as a pale-yellow solid的产率得到2-cyano-N-(4-fluoro-2-methylphenyl)acetamide
The present invention provides a fused heterocyclic derivative having a strong kinase inhibitory activity and use thereof.
The present invention relates to a compound represented by the formula
wherein each symbol is as defined in the present specification, or a salt thereof.
[EN] FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUES FUSIONNÉS ET LEUR UTILISATION
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2009136663A1
公开(公告)日:2009-11-12
The present invention provides a fused heterocyclic derivative having a strong kinase inhibitory activity and use thereof. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the present specification, or a salt thereof.
The present invention provides a fused heterocyclic derivative having a strong kinase inhibitory activity and use thereof.
The present invention relates to a compound represented by the formula
wherein each symbol is as defined in the present specification, or a salt thereof.